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Consensus sequenceG protein-coupled receptor kinases (GRKs) control the signaling and activation of G protein-coupled
receptors through phosphorylation. In this study, consensus substrate motifs for GRK2 were identi-
ﬁed from the sequences of GRK2 protein substrates, and 17 candidate peptides were synthesized to
identify peptide substrates with high afﬁnity for GRK2. GRK2 appears to require an acidic amino acid
at the 2, 3, or 4 positions and its consensus phosphorylation site motifs were identiﬁed as (D/
E)X1–3(S/T), (D/E)X1–3(S/T)(D/E), or (D/E)X0–2(D/E)(S/T). Among the 17 peptide substrates examined, a
13-amino-acid peptide fragment of b-tubulin (DEMEFTEAESNMN) showed the highest afﬁnity for
GRK2 (Km, 33.9 lM; Vmax, 0.35 pmol min1 mg1), but very low afﬁnity for GRK5. This peptide may
be a useful tool for investigating cellular signaling pathways regulated by GRK2.
Structured summary of protein interactions:
GRK2 phosphorylates beta tubulin by protein kinase assay (View interaction)
 2014 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
G protein-coupled receptor kinases (GRKs) are a family of
cytosolic serine/threonine (Ser/Thr) protein kinases. They are clas-
siﬁed into three groups based on their tissue distribution and acti-
vation characteristics: the GRK1 group [GRK1 (rhodopsin kinase)
and GRK7], the GRK2 group (GRK2 and 3), and the GRK4 group
(GRK4–6) [1]. GRKs control the signaling and activation of G pro-
tein-coupled receptors (GPCRs) through the phosphorylation of
GPCRs [1,2]. Deregulation of GRK-mediated GPCR phosphorylation
has been associated with a number of cardiovascular diseases (e.g.,
hypertension and heart failure) [1–4], brain diseases (e.g., Alzhei-
mer disease) [1,5], and with certain types of cancers [6,7]. GRK2
(formerly known as b-adrenergic receptor kinase 1) was found to
be overexpressed in various brain and cardiovascular diseases,
and is therefore considered to be a potential therapeutic targetfor these diseases [2–5]. Selective inhibition of GRK2 activity has
been shown to increase therapeutic efﬁcacies and decrease side
effects [5,8].
The identiﬁcation of target amino-acid sequence motifs
required for GRK2-mediated phosphorylation is important, both
for understanding the diversity of intracellular signaling pathways
regulated by GRK2, and for designing speciﬁc GRK2 inhibitors for
use as candidate drugs [9]. The RESA peptide (RRREEEEESAAA) is
the only small peptide so far reported to function as a substrate
for GRK2 [10], and it has been used to investigate the biochemical
characteristics of phosphorylation by GRK2 [11–14]. Note that
phosphorylation sites are indicated by bold italic type; single-letter
abbreviations for amino acids are deﬁned in the footnote of Table 1.
The RESA peptide was designed based on the observation that most
peptide substrates of GRK2 possess acidic residues on the N-termi-
nal side of the Ser/Thr phosphate acceptor residue. Reported GRK2
phosphorylation targets include b-tubulin [11,15,16], synucleins (a
and b) [17], Nedd4 [18], Nedd4-2 [18], b2-adrenergic receptor [19],
epithelial Na+ channels [20], phosducin [21], rhodopsin [22], ribo-
somal protein P2 [23], downstream regulatory element antagonist
modulator (DREAM) [24], p38 mitogen-activated protein kinase
Table 1
Substrates for GRK2 and their phosphorylation sites.
Samples GRK2 substrates Phosphorylation sites Peptide sequencesa Refs.
 Amino-terminus Carboxyl-terminus?
8 7 6 5 4 3 2 1 0 +1 +2 +3 +4 +5 +6 +7 +8
GR-11-1 b-Tubulin T409 D E M E F T E A E S N M N [11,15]
GR-11-2 b-Tubulin S420 M N D L V S E Y Q Q Y Q [11,15]
GR-11-3 b-Synuclein S118 M E P E G E S Y E D P P Q [17]
GR-11-4 a-Synuclein S129 E A Y E M P S E E G Y Q D [17]
GR-11-5 Nedd4-2 T304 G P E P W E T I S E E M N M [18]
GR-11-6 Nedd4 T466 P G W E E R T H T D G R V F [18]
GR-11-7 b2-Adrenergic receptor S401 V P S D N I D S Q G R N C [19]
GR-11-8 Epithelial Na+ channels S633 L D T M E S D S E V E A I [20]
GR-11-9 Phosducin S219 A G D V E S F L N E A [21]
GR-11-10 Rhodopsin S343 V S K T E T S Q V A P A [22]
GR-11-11 Ribosomal protein P2 S102/S105 D E K K E E S E E S D D D M G [23]
GR-11-12 DREAM S95 K K E L Q S L Y R G F K [24]
GR-11-13 p38 MAPK T123 V K C Q K L T D D H V Q F [25]
GR-11-14 PDEc T62 G M E G L G T D I T V I [26]
GR-11-15 PDGFR-b S1104 P R A E A E D S F L [30]
GR-11-16 Smad2 T197 P P L D D Y T H S I P E N [27]
GR-11-17 Ezrin/radixin T567/T564 G R D K Y K T L R Q I R Q G [28,29]
RESA R R R E E E E E S A A A [10]
a All phosphorylation sites are indicated by bold italic type. A, alanine; C, cysteine; D, aspartate; E, glutamate; F, phenylalanine; G, glycine; H, Histidine; I, isoleucine; K,
lysine; L, leucine; M, methionine; N, asparagine; P, proline; Q, glutamine; R, arginine; S, serine; T, threonine; Y, tyrosine; V, valine; and W, tryptophan.
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radixin [28,29], and platelet-derived growth factor receptor-b
(PDGFR-b) [30]. Phosphorylation of substrates by GRK2 can be
enhanced in the presence of G protein bc subunits and negatively
charged phospholipids (e.g., phosphatidylserine) [13,16,31].
The knowledge of consensus substrate motifs is very important
for designing kinase-speciﬁc peptide substrates [32,33]. Using a
motif-based proﬁle scanning approach, combined with synthetic
peptide chemistry, our group has developed highly speciﬁc peptide
substrates for protein kinase Ca [34], Ij-B kinase b [35], and Rho-
associated protein kinase 2 (Rho kinase 2/ROCK2) [36]. However,
consensus motifs for the substrates of GRK2 have not yet been
described [37].
In this study, we identiﬁed consensus substrate motifs for GRK2
from the sequences of known GRK2 protein substrates. To identify
small peptide substrates with high afﬁnity for GRK2, 17 candidate
peptide substrates were synthesized and tested using an in vitro
phosphorylation assay.
2. Materials and methods
2.1. Synthesis of peptide substrates
Peptide substrates were synthesized using standard Fmoc
chemistry, and were puriﬁed by performing high-performance
liquid chromatography. All peptides were modiﬁed by N-terminal
acetylation and C-terminal amidation. Peptide molecular weights
were veriﬁed by matrix-assisted laser desorption/ionization time-
of-ﬂight mass spectrometry (MALDI-TOF MS), as described previ-
ously [36]. Peptides with >95% purity were used as substrates for
the phosphorylation reaction with GRK2.
2.2. Phosphorylation of peptide substrates
A synthetic peptide (RRREEEEESAAA) was used as a control for
the GRK2 phosphorylation assay. The peptides were dissolved in
dimethyl sulfoxide (DMSO, at a ﬁnal concentration not exceeding
5%). The kinase activity of recombinant GRK2 (Invitrogen, Carlsbad,
CA, USA) and GRK5 (Sigma–Aldrich, St. Louis, MO, USA) towards
each peptide was determined by measuring 32P transfer from
[c-32P]ATP (6000 Ci mmol1, PerkinElmer Inc., Boston, MA, USA)to each peptide. Reagents were used according to the manufac-
turer’s instructions. Phosphorylation reactions were carried out
in 25 lL of buffer (20 mM Tris–HCl, pH 7.5, 10 mM MgCl2,
0.5 mM EGTA, 0.5 mM Na3VO4, 5 mM b-glycerophosphate,
2.5 mM dithiothreitol, 0.01% Triton X-100, 200 lM ATP and
0.1 lCi [c-32P]ATP), 50 lM peptide, and GRK2 (2.5 ng lL1 for
screening; 6.0 ng lL1 for kinetic analysis) or GRK5 (2.5 ng lL1).
The assay mixture was incubated for 10 min or 60 min at 30 C,
and the reaction was terminated by the addition of 5 lL of 30% tri-
chloroacetic acid (TCA). The reaction mixture (24 lL) was spotted
onto polyvinylidene diﬂuoride (PVDF) transfer membranes
(Hybond-P, Amersham, 2 cm  2 cm) that had been pre-wetted
with methanol prior to equilibration in water [35]. The membranes
were washed three times with 5% TCA, and the radioactivity on
each membrane was determined by liquid scintillation counting.
Kinetic parameters were determined from Lineweaver–Burk plots.
3. Results and discussion
3.1. Consensus phosphorylation site motifs for GRK2
Our design criteria for candidate substrate peptides, based on
the putative consensus phosphorylation site motifs identiﬁed in
GRK2 substrate proteins were: (1) amino-acid sequence identical
to that in parent protein substrate; (2) Ser/Thr phosphate acceptor
residue located in the middle of the peptide; and (3) peptide length
limited to 15 residues to allow easy chemical synthesis. When
multiple phosphorylation sites were reported in a target protein,
the sequence surrounding the most commonly phosphorylated
Ser/Thr residue was selected. For example, the b2-adrenergic
receptor contains four phosphorylation sites for GRK2 (Thr 384,
Ser 396, Ser 401, and Ser 407). In this case, the sequence
VPSDNIDSQGRNC (V394–C406) surrounding the Ser 401 phosphor-
ylation site was chosen, because the protein is most commonly
phosphorylated at Ser 401 [19].
Overall, GRK2 exhibited a marked preference for peptide sub-
strates with negatively charged amino acids on the N-terminal side
of the phosphorylation site, particularly at positions 2, 3, or 4
with respect to the phosphorylated Ser/Thr residue. In addition,
acidic amino acids often found at the 1 and/or the +1 positions.
Among the phosphorylation sites examined in this study, the
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Fig. 1. Results of GRK2-mediated radiolabel incorporation assays using [c-32P]ATP for 17 peptide substrates. CPM, counts per minute; ATP, adenosine triphosphate.
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consensus phosphorylation site motifs for GRK2 appeared to be
(D/E)X1–3(S/T), (D/E)X1–3(S/T)(D/E), and (D/E)X0–2(D/E)(S/T) (see
the footnote of Table 1 for single-letter abbreviations for amino
acids; X indicates any amino acid).
3.2. Phosphorylation of peptide substrates by GRK2
To identify for peptide substrates with high afﬁnity for GRK2, 17
peptide substrates were synthesized and tested for phosphoryla-
tion by GRK2. The incorporation of radioactivity (counts per
minute, CPM) for each peptide substrate in a [c-32P]ATP radiolabel-
ing assay is presented in Fig. 1. The GR-11-1 and GR-11-8 peptides,
which are based on target motifs in b-tubulin and epithelial Na+CP
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Fig. 2. (A) Sequences of ﬁve GR-11-1-derived peptide substrates of different
lengths and (B) their radiolabel incorporation levels. Each peptide substrate was
tested using the GRK2-mediated [c-32P]ATP radiolabel incorporation assay. CPM,
counts per minute; ATP, adenosine triphosphate.channel proteins, respectively, showed markedly higher radiolabel
incorporation than the other 15 peptide substrates. The highest
radiolabel incorporation was observed with the GR-11-1 peptide
substrate (DEMEFTEAESNMN). It is noteworthy that the level of
radiolabel incorporation seen with GR-11-1 was four times higher
than that observed with the RESA peptide, which is widely used as
a synthetic peptide substrate for GRK2. Based on [32P] incorpora-
tion from [c-32P]ATP, the Km value of GR-11-1 was 33.9 lM and
Vmax was 0.35 pmol min1 mg1.
In order to clarify the sequence requirements for phosphoryla-
tion by GRK2, ﬁve peptide analogs of the GR-11-1 sequence sur-
rounding the phosphorylation site were synthesized and tested for
[32P] incorporation, as above. Three shorter peptides (GR-11-1-3,
GR-11-1-4, and GR-11-1-5) showed signiﬁcantly reduced phos-
phorylation, compared with the parent GR-11-1 peptide, while
extension at the N-terminus of GR-11-1 had no signiﬁcant effect
on phosphorylation (GR-11-1-1 and GR-11-1-2). Interestingly, the
effects of removal of aspartic acid (D) at the 5 position or methio-
nyl-asparagine (MN) at the +5 and +6 positions suggest that these
residues are crucial for efﬁcient phosphorylation (Fig. 2). These
results indicate that the 13-amino-acid b-tubulin-derived sequence
corresponding to GR-11-1 represents the shortest and most effec-
tivemotif for phosphorylation byGRK2, and that the amino acid res-
idues surrounding the phosphorylation site (S/T) which binds to theC
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Fig. 3. Results of GRK2- or GRK5-mediated radiolabel incorporation assays using
[c-32P]ATP for ﬁve peptide substrates. The CPM level of substrates for GRK2 was
obtained from Figs. 1 and 2. CPM, counts per minute; ATP, adenosine triphosphate.
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and the substrate phosphorylation by GRK2.
In addition, ﬁve substrates (GR-11-1, GR-11-1-1, GR-11-1-2,
GR-11-8, and RESA) were phosphorylated by GRK5. All phosphory-
lation reactions showed very low CPM levels (<1300), meaning that
GR-11-1 and GR-11-8 have very low afﬁnities for GRK5 (Fig. 3).
GRK2 speciﬁcally phosphorylates target proteins, thereby regu-
lating downstream signaling through GPCRs. Peptide substrates
with high afﬁnity and speciﬁcity for GRK2 may therefore be useful
as research tools and/or candidate drugs in a number of cardiovas-
cular and other diseases. In the present work, the GR-11-1 peptide
(DEMEFTEAESNMN) was identiﬁed as a highly efﬁcient substrate of
GRK2, showing markedly higher incorporation of radiolabeled
phosphate than that observed for the RESA peptide, which is
widely used as a substrate of GRK2. Therefore, the GR-11-1 peptide
may be a useful tool for investigating cellular signaling pathways
regulated by GRK2.
Acknowledgments
The authors thank Ms. Sigemi Terakubo and Ms. Ninyo
Okamura for technical assistance. This work was ﬁnancially sup-
ported by a Grant-in-aid for Scientiﬁc Research (A) (KAKENHI
Grant No. 24245015) and (B) (KAKENHI Grant No. 23310085),
and a Grant-in-aid for Young Scientist (B) (KAKENHI Grant No.
24790052) from the Ministry of Education, Culture, Sports, Science,
and Technology (MEXT) of Japan.
References
[1] Gurevich, E.V., Tesmer, J.J., Mushegian, A. and Gurevich, V.V. (2012) G protein-
coupled receptor kinases: more than just kinases and not only for GPCRs.
Pharmacol. Ther. 133, 40–69.
[2] Rockman, H.A., Koch, W.J. and Lefkowitz, R.J. (2002) Seven-transmembrane-
spanning receptors and heart function. Nature 415, 206–212.
[3] Crone, S.A., Zhao, Y.Y., Fan, L., Gu, Y., Minamisawa, S., Liu, Y., Peterson, K.L.,
Chen, J., Kahn, R., Condorelli, G., Ross Jr., J., Chien, K.R. and Lee, K.F. (2002)
ErbB2 is essential in the prevention of dilated cardiomyopathy. Nat. Med. 8,
459–465.
[4] Harris, D.M., Cohn, H.I., Pesant, S. and Eckhart, A.D. (2008) GPCR signalling in
hypertension: role of GRKs. Clin. Sci. 115, 79–89.
[5] Obrenovich, M.E., Morales, L.A., Cobb, C.J., Shenk, J.C., Méndez, G.M., Fischbach,
K., Smith, M.A., Qasimov, E.K., Perry, G. and Aliev, G. (2009) Insights into
cerebrovascular complications and Alzheimer disease through the selective
loss of GRK2 regulation. J. Cell Mol. Med. 13, 853–865.
[6] Matsubayashi, J., Takanashi, M., Oikawa, K., Fujita, K., Tanaka, M., Xu, M., De
Blasi, A., Bouvier, M., Kinoshita, M., Kuroda, M. and Mukai, K. (2008)
Expression of G protein-coupled receptor kinase 4 is associated with breast
cancer tumourigenesis. J. Pathol. 216, 317–327.
[7] Kim, J.I., Chakraborty, P., Wang, Z. and Daaka, Y. (2012) G-protein coupled
receptor kinase 5 regulates prostate tumor growth. J. Urol. 187, 322–329.
[8] Reinkober, J., Tscheschner, H., Pleger, S.T., Most, P., Katus, H.A., Koch, W.J. and
Raake, P.W. (2012) Targeting GRK2 by gene therapy for heart failure: beneﬁts
above b-blockade. Gene Ther. 19, 686–693.
[9] Pitcher, J.A., Freedman, N.J. and Lefkowitz, R.J. (1998) G protein-coupled
receptor kinases. Annu. Rev. Biochem. 67, 653–692.
[10] Onorato, J.J., Palczewski, K., Regan, J.W., Caron, M.G., Lefkowitz, R.J. and
Benovic, J.L. (1991) Role of acidic amino acids in peptide substrates of the
beta-adrenergic receptor kinase and rhodopsin kinase. Biochemistry 30,
5118–5125.
[11] Pitcher, J.A., Hall, R.A., Daaka, Y., Zhang, J., Ferguson, S.S., Hester, S., Miller, S.,
Caron, M.G., Lefkowitz, R.J. and Barak, L.S. (1998) The G protein-coupled
receptor kinase 2 is a microtubule-associated protein kinase that
phosphorylates tubulin. J. Biol. Chem. 273, 12316–12324.
[12] Benovic, J.L., Onorato, J.J., Arriza, J.L., Stone, W.C., Lohse, M., Jenkins, N.A.,
Gilbert, D.J., Copeland, N.G., Caron, M.G. and Lefkowitz, R.J. (1991) Cloning,
expression, and chromosomal localization of b-adrenergic receptor kinase 2. J.
Biol. Chem. 266, 14939–14946.
[13] Onorato, J.J., Gillis, M.E., Liu, Y., Benovic, J.L. and Ruoho, A.E. (1995) The beta-
adrenergic receptor kinase (GRK2) is regulated by phospholipids. J. Biol. Chem.
270, 21346–21353.[14] Winstel, R., Ihlenfeldt, H.G., Jung, G., Krasel, C. and Lohse, M.J. (2005) Peptide
inhibitors of G protein-coupled receptor kinases. Biochem. Pharmacol. 70,
1001–1008.
[15] Yoshida, N., Haga, K. and Haga, T. (2003) Identiﬁcation of sites of
phosphorylation by G-protein-coupled receptor kinase 2 in b-tubulin. Eur. J.
Biochem. 270, 1154–1163.
[16] Haga, K., Ogawa, H. and Murofushi, H. (1998) GTP-binding-protein-coupled
receptor kinase 2 (GRK2) binds and phosphorylates tubulin. Eur. J. Biochem.
255, 363–368.
[17] Pronin, A.N., Morris, A.J., Surguchov, A. and Benovie, J.L. (2000) Synucleins are
a novel class of substrates for G protein-coupled receptor kinases. J. Biol.
Chem. 275, 26515–26522.
[18] Sanchez-Perez, A., Kumar, S. and Cook, D.I. (2007) GRK2 interacts with and
phosphorylates Nedd4 and Nedd4-2. Biochem. Biophys. Res. Commun. 359,
611–615.
[19] Fredericks, Z.L., Pitcher, J.A. and Lefkowitz, R.J. (1996) Identiﬁcation of the G
protein-coupled receptor kinase phosphorylation sites in the human b2-
adrenergic receptor. J. Biol. Chem. 271, 13796–13803.
[20] Dinudom, A., Fotia, A.B., Lefkowitz, R.J., Young, J.A., Kumar, S. and Cook, D.I.
(2004) The kinase Grk2 regulates Nedd4/Nedd4-2-dependent control of
epithelial Na+ channels. Proc. Natl. Acad. Sci. USA 101, 11886–11890.
[21] Ruiz-Gómez, A., Humrich, J., Murga, C., Quitterer, U., Lohse, M.J. and Mayor Jr.,
F. (2000) Phosphorylation of phosducin and phosducin-like protein by G
protein-coupled receptor kinase 2. J. Biol. Chem. 275, 29724–29730.
[22] Ohguro, H., Johnson, R.S., Ericsson, L.H., Walsh, K.A. and Palczewski, K. (1994)
Control of rhodopsin multiple phosphorylation. Biochemistry 33, 1023–1028.
[23] Freeman, J.L., Gonzalo, P., Pitcher, J.A., Claing, A., Lavergne, J.P., Reboud, J.P. and
Lefkowitz, R.J. (2002) b2-Adrenergic receptor stimulated, G protein-coupled
receptor kinase 2 mediated, phosphorylation of ribosomal protein P2.
Biochemistry 41, 12850–12857.
[24] Ruiz-Gómez, A., Mellström, B., Tornero, D., Morato, E., Savignac, M., Holguín,
H., Aurrekoetxea, K., González, P., González-García, C., Ceña, V., Mayor Jr., F.
and Naranjo, J.R. (2007) G protein-coupled receptor kinase 2-mediated
phosphorylation of downstream regulatory element antagonist modulator
regulates membrane trafﬁcking of Kv4.2 potassium channel. J. Biol. Chem.
282, 1205–1215.
[25] Peregrin, S., Jurado-Pueyo, M., Campos, P.M., Sanz-Moreno, V., Ruiz-Gómez, A.,
Crespo, P., Mayor Jr., F. and Murga, C. (2006) Phosphorylation of p38 by GRK2
at the docking groove unveils a novel mechanism for inactivating p38MAPK.
Curr. Biol. 16, 2042–2047.
[26] Wan, K.F., Sambi, B.S., Frame, M., Tate, R. and Pyne, N.J. (2001) The inhibitory c
subunit of the type 6 retinal cyclic guanosine monophosphate
phosphodiesterase is a novel intermediate regulating p42/p44 mitogen-
activated protein kinase signaling in human embryonic kidney 293 cells. J.
Biol. Chem. 276, 37802–37808.
[27] Ho, J., Cocolakis, E., Dumas, V.M., Posner, B.I., Laporte, S.A. and Lebrun, J.J.
(2005) The G protein-coupled receptor kinase-2 is a TGFb-inducible
antagonist of TGFb signal transduction. EMBO J. 24, 3247–3258.
[28] Cant, S.H. and Pitcher, J.A. (2005) Gprotein-coupled receptor kinase 2-mediated
phosphorylation of ezrin is required for G protein-coupled receptor-dependent
reorganization of the actin cytoskeleton. Mol. Biol. Cell 16, 3088–3099.
[29] Kahsai, A.W., Zhu, S. and Fenteany, G. (2010) G protein-coupled receptor
kinase 2 activates radixin, regulating membrane protrusion and motility in
epithelial cells. Biochem. Biophys. Acta 1803, 300–310.
[30] Hildreth, K.L., Wu, J.H., Barak, L.S., Exum, S.T., Kim, L.K., Peppel, K. and
Freedman, N.J. (2004) Phosphorylation of the platelet-derived growth factor
receptor-beta by G protein-coupled receptor kinase-2 reduces receptor
signaling and interaction with the Na+/H+ exchanger regulatory factor. J.
Biol. Chem. 279, 41775–41782.
[31] DebBurman, S.K., Ptasienski, J., Benovic, J.L. and Hosey, M.M. (1996) G protein-
coupled receptor kinase GRK2 is a phopholipid-dependent enzyme that can be
conditionally activated by G protein bc subunits. J. Biol. Chem. 271, 22552–
22562.
[32] Leung, G.C., Murphy, J.M., Briant, D. and Sicheri, F. (2009) Characterization of
kinase target phosphorylation consensus motifs using peptide SPOT arrays.
Methods Mol. Biol. 570, 187–195.
[33] Kang, J.H., Toita, R., Kim, C.W. and Katayama, Y. (2012) Protein kinase C (PKC)
isozyme-speciﬁc substrates and their design. Biotechnol. Adv. 30, 1662–1672.
[34] Kang, J.H., Asai, D., Yamada, S., Toita, R., Oishi, J., Mori, T., Niidome, T. and
Katayama, Y. (2008) A short peptide is a protein kinase C (PKC)a-speciﬁc
substrate. Proteomics 8, 2006–2011.
[35] Asai, D., Tsuchiya, A., Kang, J.H., Kawamura, K., Oishi, J., Mori, T., Niidome, T.,
Shoji, Y., Nakashima, H. and Katayama, Y. (2009) Inﬂammatory cell-speciﬁc
transgene expression system responding to Ij-B kinase beta activation. J. Gene
Med. 11, 624–632.
[36] Kang, J.H., Asai, D., Tsuchiya, A., Mori, T., Niidome, T. and Katayama, Y. (2011)
Peptide substrates for Rho-associated kinase 2 (Rho-kinase 2/ROCK2). PLoS
One 6, e22699.
[37] Pearce, L.R., Komander, D. and Alessi, D.R. (2010) The nuts and bolts of AGC
protein kinases. Nat. Rev. Mol. Cell Biol. 11, 9–22.
